Spatially resolved transcriptomic profile for C3 glomerulopathy
Spatial transcriptomic profiling using GeoMx Digital Spatial Profiler with formalin-fixed paraffin-embedded kidney biopsy specimens for C3 glomerulopathy and other glomerular disease controls (minimal change disease, membranous nephropathy, focal ...
Jung Hun Koh (17992498)
core +1 more source
C3 glomerulopathy. Clinical predictors of long-term outcomes [PDF]
Background. C3 glomerulopathy is a rare glomerular disease characterized by dysregulation of the alternative complement pathway. Its clinical course is often unpredictable, with an increased risk of progression to chronic kidney disease.
Groppa, Liliana +2 more
core
Dense deposit disease in a child with febrile sore throat
Saudi Journal of Kidney Diseases and Transplantation, 2017 Dense deposit disease or membranoproliferative glomerulonephritis type II is a rare glomerulopathy characterized on renal biopsy by deposition of abnormal electron-dense material in the glomerular basement membrane.
Giovanni Conti +4 more
doaj
C3 glomerulonephritis: a new category of glomerulonephritis with etiopathogenic implications
Iatreia, 2015 Introduction: Glomerulonephritis with only deposits of C3 (GN-C3) could involve alteration on the complement alternative pathway.Objective: To describe retrospectively a series of GNC3 cases and to determine the frequency with which patients continue ...
Taborda Murillo, Alejandra +2 more
doaj
Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options
C3 glomerulopathy is a rare disease, characterized by an abnormal activation of the complement’s alternative pathway that leads to the accumulation of the C3 component in the kidney.
Giulia Bartoli +7 more
core +1 more source
Does pregnancy modify disease activity in C3 glomerulopathy? [PDF]
CEN Case RepYamaguchi Y +4 more
europepmc +1 more source
A Beacon of Hope: Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN. [PDF]
Clin J Am Soc NephrolOwoyemi I, Moxey-Mims MM.
europepmc +1 more source
Pegcetacoplan as a targeted C3 inhibitor in C3 glomerulopathy and immune-complex MPGN. [PDF]
Ann Med Surg (Lond)Habib E, Hajj F.
europepmc +1 more source
Charting the Course of Recurrent C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN in Kidney Transplant Recipients. [PDF]
Clin J Am Soc NephrolWong EKS.
europepmc +1 more source
C3 Glomerulopathy: recent advances and an update on management. [PDF]
J Bras NefrolPalma LMP, Barbosa MINH, Sethi S.
europepmc +1 more source